Keesari, P. R., Jain, A., Ganampet, N. R., Subhasri, G. S. D., Edusa, S., Muslehuddin, Z., Theik, N. W. Y., Palisetti, S., Salibindla, D., Manaktala, P. S., & Desai, R. (2024). Association between prediabetes and BC: a comprehensive meta-analysis. Breast Cancer Research and Treatment, 204(1), 1–13.
Ji, X., Huang, X., Li, C., Guan, N., Pan, T., Dong, J., & Li, L. (2024). Effect of tumor-associated macrophages on the pyroptosis of BC tumor cells. Cell Communication and Signaling: CCS, 21(1), 197.
Decorads, C. E., Lambert, A., Roch, V., Imbert, L., Perrin, M., Claudin, M., Doyen, M., Citerne, Q., Lamiral, Z., Peiffert, D., Henneton, C., & Marie, P. Y. (2024). Association between baseline hemodynamic indices, cardiotoxicity risk, and survival in women with BC. Journal of Nuclear Cardiology, 35, 101849.
Wu, C. H., Yeh, C. T., & Lin, K. H. (2020). Thyroid hormones suppress FOXM1 expression to reduce liver cancer progression. Oncology Reports, 44(4), 1686–1698.
Zheng, S., Zhou, C., Wang, Y., Li, H., Sun, Y., & Shen, Z. (2020). TRIM6 promotes colorectal cancer cells proliferation and response to thiostrepton by TIS21/FoxM1. Journal of Experimental & Clinical Cancer Research: CR, 39(1), 23.
Article CAS PubMed Central Google Scholar
Tian, J. H., Mu, L. J., Wang, M. Y., Zeng, J., Long, Q. Z., Bin-Guan, Wang, W., Jiang, Y. M., Bai, X. J., & Du, Y. F. (2021). FOXM1-dependent transcriptional regulation of EZH2 induces proliferation and progression in prostate cancer. Anti-cancer Agents in Medicinal Chemistry, 21(14), 1835–1841.
Article CAS PubMed Google Scholar
Madhi, H., Lee, J. S., Choi, Y. E., Li, Y., Kim, M. H., Choi, Y., & Goh, S. H. (2022). FOXM1 inhibition enhances the therapeutic outcome of lung cancer immunotherapy by modulating PD-L1 expression and cell proliferation. Advanced Science (Weinheim), 9(29), e2202702.
Wang, X., Dou, N., Wang, J., Zhang, Y., Li, Y., & Gao, Y. (2021). FOXM1-induced miR-552 expression contributes to pancreatic cancer progression by targeting multiple tumor suppressor genes. International Journal of Biological Sciences, 17(4), 915–925.
Article CAS PubMed PubMed Central Google Scholar
Tabnak, P., Hasanzade Bashkandi, A., Ebrahimnezhad, M., & Soleimani, M. (2023). Forkhead box transcription factors (FOXOs and FOXM1) in glioma: from molecular mechanisms to therapeutics. Cancer Cell International, 23(1), 238.
Article CAS PubMed PubMed Central Google Scholar
Sun, H. L., Men, J. R., Liu, H. Y., Liu, M. Y., & Zhang, H. S. (2020). FOXM1 facilitates BC cell stemness and migration in YAP1-dependent manner. Archives of Biochemistry and Biophysics, 685, 108349.
Article CAS PubMed Google Scholar
Jin, Z., Tao, S., Zhang, C., Xu, D., & Zhu, Z. (2022). KIF20A promotes the development of fibrosarcoma via PI3K-Akt signaling pathway. Experimental Cell Research, 420(1), 113322.
Article CAS PubMed Google Scholar
Jin, Z., Peng, F., Zhang, C., Tao, S., Xu, D., & Zhu, Z. (2023). Expression, regulating mechanism and therapeutic target of KIF20A in multiple cancer. Heliyon, 9(2), e13195.
Article CAS PubMed PubMed Central Google Scholar
Nakamura, M., Takano, A., Thang, P. M., Tsevegjav, B., Zhu, M., Yokose, T., Yamashita, T., Miyagi, Y., & Daigo, Y. (2020). Characterization of KIF20A as a prognostic biomarker and therapeutic target for different subtypes of BC. International Journal of Oncology, 57(1), 277–288.
Article CAS PubMed Google Scholar
Oumeddour, A. (2023). Screening of potential hub genes and key pathways associated with BC by bioinformatics tools. Medicine (Baltimore), 102(11), e33291.
Article CAS PubMed Google Scholar
Li, Y., Guo, H., Wang, Z., Bu, H., Wang, S., Wang, H., Fang, H., Liu, Z., & Kong, B. (2023). Cyclin F and KIF20A, FOXM1 target genes, increase proliferation and invasion of ovarian cancer cells. Experimental Cell Research, 395(2), 112212.
Fang, K., Gong, M., Liu, D., Liang, S., Li, Y., Sang, W., & Zhu, R. (2023). FOXM1/KIF20A axis promotes clear cell renal cell carcinoma progression via regulating EMT signaling and affects immunotherapy response. Heliyon, 9(12), e22734.
Article CAS PubMed PubMed Central Google Scholar
Yu, H., Xu, Z., Guo, M., Wang, W., Zhang, W., Liang, S., Xu, Z., Ye, J., Zhu, G., Zhang, C., & Lin, J. (2020). FOXM1 modulates docetaxel resistance in prostate cancer by regulating KIF20A. Cancer Cell International, 20(1), 545.
Article CAS PubMed PubMed Central Google Scholar
Wei, J., Chen, X., Li, Y., Li, R., Bao, K., Liao, L., Xie, Y., Yang, T., Zhu, J., Mao, F., Ni, S., Jia, R., Xu, X., & Li, J. (2022). Cucurbitacin B-induced G2/M cell cycle arrest of conjunctival melanoma cells mediated by GRP78-FOXM1-KIF20A pathway. Acta Pharmaceutica Sinica B, 12(10), 3861–3876.
Article CAS PubMed PubMed Central Google Scholar
Dalby, B., Cates, S., Harris, A., Ohki, E. C., Tilkins, M. L., Price, P. J., & Ciccarone, V. C. (2004). Advanced transfection with lipofectamine 2000 reagent: primary neurons, siRNA, and high-throughput applications. Methods, 33(2), 95–103.
Article CAS PubMed Google Scholar
Wen, N., Wang, Y., Wen, L., Zhao, S. H., Ai, Z. H., Wang, Y., Wu, B., Lu, H. X., Yang, H., Liu, W. C., & Li, Y. (2014). Overexpression of FOXM1 predicts poor prognosis and promotes cancer cell proliferation, migration and invasion in epithelial ovarian cancer. Journal of Translational Medicine, 12, 134.
Article PubMed PubMed Central Google Scholar
Clément, T., Salone, V., & Rederstorff, M. (2015). Dual luciferase gene reporter assays to study miRNA function. Methods in Molecular Biology, 1296, 187–198.
Wang, N., Liu, W., Zheng, Y., Wang, S., Yang, B., Li, M., Song, J., Zhang, F., Zhang, X., Wang, Q., & Wang, Z. (2018). CXCL1 derived from tumor-associated macrophages promotes breast cancer metastasis via activating NF-κB/SOX4 signaling. Cell Death & Disease, 9(9), 880.
Korde, L. A., Somerfield, M. R., Carey, L. A., Crews, J. R., Denduluri, N., Hwang, E. S., Khan, S. A., Loibl, S., Morris, E. A., Perez, A., Regan, M. M., Spears, P. A., Sudheendra, P. K., Symmans, W. F., Yung, R. L., Harvey, B. E., & Hershman, D. L. (2021). Neoadjuvant chemotherapy, endocrine therapy, and targeted therapy for BC: ASCO guideline. Journal of Clinical Oncology, 39(13), 1485–1505.
Article CAS PubMed PubMed Central Google Scholar
Jackson, E. B., & Chia, S. K. L. (2023). Sequencing of endocrine and targeted therapies in hormone-sensitive, human epidermal growth factor receptor 2-negative advanced BC. Journal of Clinical Oncology, 41(24), 3976–3983.
Article CAS PubMed Google Scholar
He, R., He, Y., Du, R., Liu, C., Chen, Z., Zeng, A., & Song, L. (2023). Revisiting of TAMs in tumor immune microenvironment: Insight from NF-κB signaling pathway. Biomedicine and Pharmacotherapy, 165, 115090.
Article CAS PubMed Google Scholar
Li, M., Yang, Y., Xiong, L., Jiang, P., Wang, J., & Li, C. (2023). Metabolism, metabolites, and macrophages in cancer. Journal of Hematology & Oncology, 16(1), 80.
Song, J. N., Liu, K., Mei, J., Wang, L., Lin, J., Du, P., Liu, Y. C., Wan, Y., Wong, R., Yin, J. Y., & Wang, P. Y. (2023). Defined surface physicochemical cues inhibit M1 polarization of human macrophages using colloidal self-assembled patterns. ACS Applied Materials & Interfaces, 15(30), 35832–35846.
Liu, S., Zhang, H., Li, Y., Zhang, Y., Bian, Y., Zeng, Y., Yao, X., Wan, J., Chen, X., Li, J., Wang, Z., & Qin, Z. (2021). S100A4 enhances protumor macrophage polarization by control of PPAR-γ-dependent induction of fatty acid oxidation. Journal for Immunotherapy of Cancer, 9(6), e002548.
Article PubMed PubMed Central Google Scholar
Liu, G., Yin, L., Ouyang, X., Zeng, K., Xiao, Y., & Li, Y. (2020). M2 macrophages promote HCC cells invasion and migration via miR-149-5p/MMP9 signaling. Journal of Cancer, 11(5), 1277–1287.
Article CAS PubMed PubMed Central Google Scholar
Deng, C., Huo, M., Chu, H., Zhuang, X., Deng, G., Li, W., Wei, H., Zeng, L., He, Y., Liu, H., Li, J., Zhang, C., & Chen, H. (2024). Exosome circATP8A1 induces macrophage M2 polarization by regulating the miR-1-3p/STAT6 axis to promote gastric cancer progression. Molecular Cancer, 23(1), 49.
Comments (0)